ELUT
Elutia Inc.NASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$42.44M
P/E Ratio
—
EPS
$-0.65
Beta
0.76
52W High
$2.64
52W Low
$0.50
50-Day MA
$1.08
200-Day MA
$1.00
Dividend Yield
—
Profit Margin
400.20%
Forward P/E
—
PEG Ratio
—
About Elutia Inc.
Elutia Inc., a commercial-stage company, engages in developing and commercializing drug-eluting biomatrix technology to enhance surgical outcomes. The company is headquartered in Silver Spring, Maryland.
Fundamentals
| Revenue (TTM) | $12.46M |
| Gross Profit (TTM) | $7.02M |
| EBITDA | $-19.30M |
| Operating Margin | -184.40% |
| Return on Equity | 0.00% |
| Return on Assets | -26.40% |
| Revenue/Share (TTM) | $0.29 |
| Book Value | $0.52 |
| Price-to-Book | 1.88 |
| Price-to-Sales (TTM) | 3.41 |
| EV/Revenue | 1.459 |
| EV/EBITDA | -3.33 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -48.40% |
| Shares Outstanding | $44.21M |
| Float | $25.02M |
| % Insiders | 3.40% |
| % Institutions | 45.72% |
Historical Volatility
HV 10-Day
84.73%
HV 20-Day
72.37%
HV 30-Day
63.24%
HV 60-Day
56.82%
HV Rank
27.8%
Volatility is currently expanding
Analyst Ratings
Consensus ($5.00 target)
1
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026